1.IntroductionPhotoacoustic (PA) imaging is an emerging medical imaging technique that enables detailed visualization of tissue structures and functional information.1,2 The basis of PA imaging lies in the PA effect, a physical phenomenon in which acoustic waves are generated through light absorption.1,3,4 The transformation of PA effects from a theoretical concept to a valuable imaging modality has taken over a century of development.5,6 In recent years, numerous research groups and companies have developed medical devices and processing systems available for human imaging.1,2,6–8 Typically, PA imaging devices consist of several essential components, including a short-pulsed laser for generating PA signals, an ultrasonic transducer or transducer array for detecting PA signals, a data-acquisition system for amplifying and digitizing PA signals, and a computer for forming image.1,6 As PA imaging merges laser-induced optical excitation with ultrasound (US) detection, it has advantages for clinical applications as follows: (1) PA imaging allows for noninvasive functional, metabolic, and histological imaging using endogenous contrasts such as hemoglobin [oxygenated hemoglobin (), deoxygenated hemoglobin (Hb), total hemoglobin (HbT), also known as total blood volume (TBV)], lipids, and water (Fig. 1);10–16 (2) PA imaging surpasses the penetration limitations of conventional optical methods, making it superior for deep tissue imaging compared with pure optical imaging techniques;17 (3) PA imaging can integrate with other imaging modalities, facilitating multimodal approaches that enhance diagnostic accuracy;18 and (4) PA imaging offers portability in a safe way, making it suitable for longitudinal patient monitoring.1,19–22 Owing to these advantages, PA imaging has received significant attention in medical research.7,13,23 Here, we review promising clinical applications of PA imaging, with a specific focus on tumors, autoimmune diseases, inflammatory conditions, and endocrine disorders. The literature reporting human imaging studies, especially those involving stand-alone multispectral optoacoustic tomography (MSOT) and hybrid PA and US systems, was primarily reviewed. The aim of this review is to highlight the current advancements in PA imaging. The concluding segment will briefly discuss the challenges that still need to be addressed in PA imaging. 2.TumorMalignant tumor is the primary cause of mortality and acts as one of the most important barriers to increasing life expectancy.24,25 Updated epidemiological data indicate that there were new cases of cancer and nearly 10.0 million cancer-related deaths worldwide.25 Hypoxia is a significant hallmark in solid tumors, resulting from the imbalance between the tumor cell proliferation and the available blood supply (Fig. 1).26,27 This intricate hypoxia microenvironment further leads to the regulation of molecular signaling cascades responsible for fundamental cellular processes, including cell cycle progression and angiogenesis. Tumor-associated hypoxia is related to oncological pathophysiology, including disease progression, therapeutic resistance, and poor outcome.28–30 PA imaging emerges as a compelling paradigm for visualizing the intricate landscape of tumor hypoxia, thereby facilitating early diagnosis and precise evaluation of the tumor.27,31,32 Its efficacy has been explored in diverse tumors, including breast tumors, ovarian neoplasms, thyroid nodules, and cutaneous malignancies. 2.1.Breast TumorBreast tumor is the most common cancer and stands as the primary contributor to cancer-related mortality among women.25 The overlap in the morphological features between benign and malignant breast tumors poses a great clinical challenge. PA imaging is a valuable modality for elucidating functional intricacies within breast tumors.33 In 2011, PA tomography was applied for imaging the vascularity and oxygenation of invasive breast tumors and ductal carcinoma in situ.34 The lesions exhibited an average oxygenation saturation () of 78.6%, along with a concentration of HbT measuring .34 Handheld US combined with MSOT also shows the ability for breast tumor imaging.35–41 MSOT unveiled a pattern of breast cancer characterized by rim enhancement and a diminished core PA signal, evident in both and TBV images. This pattern correlated with peripheral perfusion but reduced core blood perfusion within the tumor. The findings were validated through postoperative anti-CD31 staining.35,36 The precision of breast tumor diagnosis may be improved as PA imaging could provide functional information. The analysis using MSOT revealed significant distinctions in TBV between tumors and normal tissues. Interestingly, disruptions were observed in the water and fat lipid layers in cancerous tissues, potentially suggesting the infiltration of tumors into the adipose tissue.35 An integrated MSOT/US imaging system exhibited significantly higher hemoglobin signals in invasive carcinoma compared with healthy tissues, indicating increased perfusion in tumor and the tumor environment.37 Researchers have also explored various quantitative strategies for characterizing breast tumors. Using a three-dimensional (3D) PA/US functional imaging platform, researchers identified that invasive breast cancer (stage T1) exhibited a 7.7% lower average volumetric compared with benign tumors and a 3.9% decrease compared with healthy breast tissue, both statistics significantly. Employing an threshold of 78.2%, the model achieved high sensitivity (100%) but moderate specificity (62.5%), resulting in an area under the curve (AUC) of 0.81 for T1 invasive breast cancer differentiation.39 Further quantitative and semi-quantitative analysis focused on PA signal spatial distribution [Fig. 2(a)].40 The malignant group displayed significantly greater relative PA signal differences between surrounding/peripheral region and central regions compared with the benign group. A diagnostic model exhibited a strong diagnostic capacity for distinguishing malignancies from benign lesions (sensitivity: 80.8%, specificity: 85.7%, and AUC: 86.5%).40 Regarding breast intraductal lesions, intraductal lesions exhibited lower compared with benign lesions. A diagnostic model, which combined PA-indicated interval vessel data and scores, achieved an accuracy rate of 90% sensitivity and 87.5% specificity when discriminating intraductal lesions from benign lesions [Fig. 2(a)].41 Interestingly, the spatial distribution and spectral analysis of the PA signal may also help distinguish subtypes of breast cancer.45,46 Luminal breast cancers (both luminal A and luminal B) have exhibited higher external PA signals and lower internal PA signals than those of human epidermal growth factor receptor 2-positive and triple-negative cancers.45 The American College of Radiology Breast Imaging Report and Data System (BI-RADS) system is a recognized protocol for diagnosing breast conditions, with its primary emphasis on morphological features of lesions. The incorporation of PA/US enhances the specificity of breast tumor evaluation when compared with grayscale US in isolation.47 Subsequent investigations endeavored to incorporate the functional data from PA imaging to upgrade and downgrade BI-RADS scores for potentially malignant and benign lesions correspondingly. Benign tumors categorized as BI-RADS 4a could potentially be reclassified to lower categories, thereby decreasing the need for unnecessary biopsies and subsequent follow-up assessments. However, it is important to note that, in a small number of cases, there is a risk of inappropriate reclassification.48 In the case of intraductal lesions, the PA/US approach led to the upgrading of 40% breast intraductal lesions and the downgrading of 50% benign lesions compared with the BI-RADS system.41 2.2.Ovarian TumorOvarian tumors encompass a spectrum of classifications, including benign, borderline, and malignant. Most ovarian malignancies are diagnosed with metastasis, contributing to high gynecological cancer mortality.49,50 Early differentiation of malignancies from benign/normal masses is important, offering opportunities for prompt multidisciplinary intervention. Researchers at Washington University School of Medicine employed a transvaginal PA/US system to differentiate ovarian cancer from benign/normal ovaries. Both quantification and spatial distribution of hemoglobin contributed significantly. Invasive epithelial cancers exhibited a significantly higher mean relative HbT (rHbT) and displayed an expansive rHbT distribution. By contrast, benign/normal ovaries exhibited scattered distribution. Moreover, the average in invasive epithelial cancers, borderline tumors, and stromal tumors was significantly reduced compared with that in benign or normal ovaries [Fig. 2(b)].42 Further enhancement in classification efficacy was achieved through the application of a generalized linear model and support vector machines, increasing AUC from 0.89 to 0.92, and 0.92 to 0.93, respectively.51 Addressing measurement errors, researchers investigated a multipixel method for rHbT and estimation. Machine learning models based on support vector machine models trained with significant features achieved an AUC of 0.93 in distinguishing malignant from benign/normal tumors.52 Moreover, a UNet model, enhanced by US, was developed to improve the accuracy of reconstructing optical absorption distributions within lesions, resulting in an AUC of 0.94.53 2.3.Thyroid NoduleEpidemiological investigations estimate that 4% to 7% of adults have palpable thyroid nodules, with imaging studies identifying nodules up to 10 times more frequently.54 Although thyroid nodules are relatively common, thyroid cancer is rare, representing of all malignancies.25 Clinically, the primary difficulty lies in distinguishing patients with malignant nodules from those with benign nodules. MSOT exhibits the ability to resolve both intranodular microvasculature and extrathyroidal blood vessels, which was verified by histopathology.55 Researchers use multiparametric PA imaging to classify papillary thyroid carcinoma (PTC) nodules.56 The PTC nodule had lower compared with benign nodules, aligning with the hypothesis of tumor-related hypoxia [Fig. 2(c)].43,56 A new scoring system in combination with the American Thyroid Association Guideline achieved 83% sensitivity and 93% specificity, potentially reducing unnecessary biopsies in individuals with thyroid nodules.56 2.4.Skin CancerSkin cancer ranked as the fourth most prevalent new cancer globally.25 Employing 2D and 3D handheld scanners, MSOT efficiently distinguished tumors and their oxygenation characteristics from normal skin.44,57,58 Measurements of the tumor dimension through MSOT correlated well with histology findings from excised tumors.44,59 Real-time 3D imaging could offer insights into the morphology of lesions and the associated neo-vasculature, serving as an indicator of tumor aggressiveness44 [Fig. 2(d)]. 2.5.Surgical Guidance and Therapeutic Efficacy PredictionPA imaging has been investigated as a method of improving surgical guidance, with a specific focus on improving tumor localization and minimizing damage to non-tumor structures such as nerves and vasculature.60 This potential application has been explored in a range of tumor types, including pancreatic cancer61 and pituitary tumors.62 Moreover, researchers exploited PA imaging-derived features, notably tumor oxygenation, for predicting treatment responses in cancer patients. Patient-derived xenograft (PDX) models can be used to assess treatment outcomes.63–67 In the cases of head and neck cancer64 and triple-negative breast cancer66 PDX models, the identification of a rise in tumor after radiotherapy detected by PA imaging was linked to a notable suppression in tumor growth. The significance of alterations in levels as a predictive factor for treatment response has been highlighted in breast cancer cases treated with Bevacizumab67 and in pancreatic cancer cases responding to suboptimal Cabozantinib.68 In conclusion, PA imaging may be a straightforward, noninvasive, and cost-effective approach for anticipating therapy efficacy. 3.Autoimmune and Inflammatory Diseases3.1.Rheumatoid Arthritis, Psoriatic Arthritis, and OsteoarthritisRheumatoid arthritis (RA) is a common chronic inflammatory disorder, afflicting around 0.5% to 1% of the general population globally.69 It is characterized by progressive inflammation of synovial leading to degradation of cartilage, erosion of bone, and subsequent disability.70 US synovitis scoring provides an accessible, secure, and widely employed tool for assessing and monitoring RA’s disease progress.71 However, gray-scale US might not comprehensively visualize inflamed synovium, and power Doppler US exhibits limitations in detecting microvessels.72,73 Consequently, researchers are exploring the utility of PA in detecting subtle inflammatory lesions in RA. Metacarpophalangeal joints of RA patients revealed pronounced hyperemia and hypoxia in inflamed synovium, indicative of heightened metabolic demand and relatively inadequate oxygen supply.74 Elevated PA signals were detected in RA patients who had evident synovitis, and there was a strong correlation with power Doppler US findings.75 Zhao et al.76 developed a semi-quantic PA/US scoring system evaluating seven small joints in RA patients. This PA score exhibited strong positive correlations with key clinical disease activity indices of RA [Fig. 3(a)].76 Classification of thickened synovium into hyperoxia, intermediate oxygenation status, and hypoxia based on values’ coloration revealed insightful distinctions. RA patients with hyperoxic synovium displayed a greater abundance of vasculature depicted by Doppler US in comparison with those with hypoxic and intermediate synovium. Individuals with an intermediate oxygen status had lower clinical disease activity indices when compared with those with hypoxia. Notably, the identification of hypoxia within thickened synovium through PA imaging was associated with reduced vascularization and increased disease activity in RA [Fig. 3(a)].77 Psoriatic arthritis (PsA) is a heterogeneous inflammatory disorder involving joint, entheses, or skin/nail psoriasis.79,80 The first step in PsA patent management is the precise and prompt diagnosis that enables timely therapeutic interventions, primarily focusing on the recognition of inflammatory musculoskeletal disease manifestations.80 Capitalizing on its high sensitivity to inflammation, researchers use MSOT to scrutinize finger joints in PsA patients. The semi-quantitative evaluation of the and Hb PA signals demonstrated that blood content and oxygenation were significantly elevated in PsA patients when compared with individuals from healthy group. This observation underscored the potential of MSOT in the early stage detection of PsA-associated inflammation.81 Osteoarthritis (OA) is the most common joint disorder mainly impacting the diarthrodial joints.82 Evolving from a cartilage-limited perspective, the pathophysiology conception now embraces OA as a multifactorial disease affecting the entirety of the joint structure.83 In a pilot study, researchers employed multispectral quantitative PA tomography to investigate distal interphalangeal joints of OA patients. Compared with normal joints, OA-affected joints displayed significantly elevated water content, decreased , and increased acoustic velocity.84 3.2.Systemic Sclerosis and Raynaud’s PhenomenonSystemic sclerosis (SSc) is an autoimmune-driven connective tissue disorder identified by microangiopathy and subsequent widespread systemic fibrosis.85,86 In the early stage of the disease, vascular abnormalities become evident in small blood vessels, and eventually advance to obliterative vasculopathy, leading to issues such as tissue hypoxia, oxidative stress, and vascular complications.86 Raynaud’s phenomenon (RP), marked by pronounced peripheral vasospasm triggered by cold or emotional stress, can lead to severe outcomes including amputation. RP might be primary or secondary, as observed in SSc and other conditions.87 The inconspicuous alteration in the nail fold microscopic patterns in early SSc patients may find resolution through PA, potentially addressing the clinical imperative for early-stage diagnosis. Early stage SSc and established SSc patients exhibited significantly diminished levels and pronounced skin thickening, distinguishing them from individuals afflicted by primary RP or healthy volunteers [Fig. 3(b)].78,88,89 Similar results have been obtained using MSOT/US. and HbT of subcutaneous finger tissue measured by MSOT were significantly lower in SSc patients in comparison with those in healthy volunteers.90 Although the vascular volume remained similar between SSc and healthy control patients, oxygenation within the digital arteries was reduced in SSc patients, indicative of functional impairment. The increase in oxygenation after occlusion release was significantly reduced in individuals with SSc in comparison with the healthy control.89 Utilizing PA, the differentiation of SSc-RP from healthy volunteers achieved a baseline AUC of 0.72, with elevated diagnosis accuracy observed post-cold stimulus (5 min: , 15 min: ).91 Furthermore, significantly lower MSOT values in progressive SSc patients compared with those with stable disease were observed, indicating the potential of MSOT to evaluate the disease activity of SSc and monitor therapeutic responses.90 3.3.Giant Cell ArteritisGiant cell arteritis (GCA) is the most common systemic vasculitis in adults.92 Prominent manifestations include headache, jaw claudication, and visual symptoms, with irreversible vision loss being the most severe complication.93 Temporal artery biopsy is the gold diagnostic standard for GCA. Noninvasive PA methods are under investigation for early GCA diagnosis. Spectral analysis and the pixel-classification algorithm generated images that closely resembled the findings observed in histopathological examinations. By utilizing minimally supervised spectral analysis, images resembling histology were produced, providing clear delineation between the artery wall and the lumen. Moreover, the PA spectra were successfully distinguished between individuals with biopsy-confirmed GCA and controls.94 3.4.Inflammatory Bowel DiseaseIdiopathic inflammatory bowel disease is a chronic systemic inflammatory disease predominantly affecting the gastrointestinal tract, encompassing Crohn’s disease (CD) and ulcerative colitis (UC).95 Uncontrolled inflammation is associated with higher complication rates and mortality, which prompts the exploration of novel noninvasive diagnostic and assessment modalities.96 Researchers used MSOT to evaluate intestinal inflammation in CD patients. US-guided MSOT enabled rapid and noninvasive evaluation of HbT, , and Hb content within the intestinal wall. This approach allowed for the quantification of tissue perfusion and oxygenation, which were dependent on hemoglobin and reflected the impact of inflammation.97 Significant distinctions in measurements at 760 nm and unmixed HbT were observed between remission CD patients identified by endoscopic and active CD patients.98 In pediatric patients with CD and UC, HbT signals exhibited a significant increase in the terminal ileum of CD patients and in the sigmoid colon of UC patients. There parameters correlated well with the disease activity, highlighting the potential for noninvasive evaluation in pediatric patients with IBD.99 4.Endocrinology and Metabolism Disease4.1.Diabetes MellitusDiabetes mellitus (DM) is a prevalent health issue in the 21st century, presenting a significant public health challenge.100 DM-related complications include both macrovascular and microvascular conditions, including coronary heart disease, peripheral arterial disease, diabetic kidney disease, and retinopathy.101 PA imaging, capable of monitoring perfusion changes,102 and measuring in artery or capillary vessels,19,103–105 hold promise for staging DM severity via quantitative imaging of vascular complications. Researchers found that, after occlusion, DM patients exhibited a distinctive peripheral hemodynamic response and had lower levels than healthy individuals, highlighting the capacity of PA imaging to detect vascular dysfunction of DM (Fig. 4).106 In addition, MSOT emerged as a tool to visualize peripheral vasculature and assess flow-mediated dilation, which can characterize macrovascular endothelial function—a biomarker for early stage atherosclerosis accentuated in DM.107 MSOT also displayed potential in imaging peripheral arterial disease, revealing significantly reduced , HbT, and compared with healthy volunteers.108 Furthermore, MSOT facilitates the assessment of endocrine and metabolic functions by visualizing lipids and adipose tissue. Reber et al.109 observed differences in brown adipose tissue composition between DM and healthy volunteers. Among serious complications associated with DM, poor wound healing, persistent ulceration, and the subsequent need for limb amputation pose significant challenges.110 Previous studies demonstrated the utility of PA imaging in monitoring wound healing. A case study showed that higher perfusion and were correlated with surgical observations. In a cohort, radial artery oxygenation increased significantly after hyperbaric oxygen therapy.111 Similar outcomes emerged from studies measuring following topical hemoglobin treatment, with increased predicting treatment response.112 Moreover, PA imaging can directly visualize angiogenesis.113 Therapy-responsive patients exhibited evident indications of angiogenesis and a significantly increased rate of PA signals. Negative correlations were detected between the intensity of PA signals and the size of the wound. An increased rate of PA signal or angiogenesis could predict the time of healing within the first 30 days of monitoring.113 4.2.Thyroid DiseaseThe thyroid gland is an important endocrine organ, producing thyroxine to regulate the organ function, metabolic condition, and protein synthesis rate. For imaging of thyroid functional pathology such as Graves’ disease (hyperthyroidism) or Hashimoto thyroiditis (hypothyroidism), existing modalities involve assessing the blood flow via Doppler US or tracking the uptake of radioactive contrast agents.114 PA could reveal microvessels in the human thyroid that escape Doppler US.115 Further, MSOT could image lipids and water, alongside vascularization and oxygenation predicted on hemoglobin.19 In Graves’ disease patients, and HbT were significantly elevated while fat content exhibited significant reduction, distinguishing them from healthy controls.43 These initial investigations underscore the capability of PA imaging to offer rapid and radiation-free functional thyroid imaging.19 5.Future and ChallengesOver the past decades, PA imaging has demonstrated significant potential in clinical applications, as outlined in this review. The next decade is poised to witness a substantial increase in the utilization of PA imaging in clinical practice, owing to its advantages in penetration depth, functional imaging capabilities, multimodality integration, and safety. However, several challenges remain for the incorporation of PA imaging into routine medical practice. First, the primary challenge lies in the limited penetration depth.116 Although PA imaging provides enhanced depth compared with purely optical imaging techniques, inherent attenuation of light energy restricts its penetration to in vivo clinical settings.117,118 Consequently, imaging internal organs such as the heart, liver, pancreas, and uterus in humans remains a challenging task. The exploration of advanced laser technologies and advanced signal processing techniques may help increase the penetration depth. Second, the differentiation of imaging contrast is important. Although endogenous contrasts are various, such as hemoglobin, water, lipid, and melanin, their absorption spectra often overlap, posing difficulties for algorithms to distinguish them, even with MSOT [Fig. 1(b)].119 This limitation hinders the accuracy of signal quantification and brings uncertainty to PA imaging.120,121 Investigating contrast agents and employing deep learning algorithms may fascilitate the differentiation of imaging contrasts.122,123 Third, the absence of standardized protocols is another critical concern. Unlike mature imaging modalities such as MRI and CT, PA imaging lacks standardized procedures and quality control measures.121,124 This can introduce variability in image quality and interpretation, making it a great challenge to compare results across various studies, institutions, and devices.7 Establishing education and training procedures for data acquisition and interpretation is imperative. Finally, the deficiency in large-scale clinical validation poses an obstacle. The reliability, accuracy, and value of PA imaging for specific diagnosis and evaluation need to be thoroughly established through well-designed clinical trials.124 6.ConclusionsDespite extant challenges, PA imaging exhibits significant promise for both research and clinical applications across diverse fields such as tumors, autoimmune diseases, inflammatory conditions, endocrine disorders, and so on. From bench to bedside, PA imaging aims to facilitate the diagnosis, evaluation, treatment, and prognosis anticipation. Through sustained collaborative efforts among researchers, clinicians, and technologists, PA imaging may pave the way for personalized patient management. As a result, it has the potential to transition from an uncommon technology to a routine strategy, contributing to more precise medical approaches in the foreseeable future. Code and Data AvailabilityData sharing is not applicable to this review, as no new data were created or analyzed. AcknowledgmentsThis study was supported by the National Natural Science Foundation of China (Grant Nos. 62325112, U22A2023, and 61971447), the National High Level Hospital Clinical Research Funding (Grant Nos. 2022-PUMCH-C-009, 2022-PUMCH-B-064, and 2022-PUMCH-D-002), and the China Postdoctoral Science Foundation (Grant No. 2022TQ0044). ReferencesL. V. Wang and J. Yao,
“A practical guide to photoacoustic tomography in the life sciences,”
Nat. Methods, 13
(8), 627
–638 https://doi.org/10.1038/nmeth.3925 1548-7091
(2016).
Google Scholar
W. Choi et al.,
“Clinical photoacoustic imaging platforms,”
Biomed. Eng. Lett., 8
(2), 139
–155 https://doi.org/10.1007/s13534-018-0062-7
(2018).
Google Scholar
K. S. Valluru, K. E. Wilson and J. K. Willmann,
“Photoacoustic imaging in oncology: translational preclinical and early clinical experience,”
Radiology, 280
(2), 332
–349 https://doi.org/10.1148/radiol.16151414 RADLAX 0033-8419
(2016).
Google Scholar
P. K. Upputuri and M. Pramanik,
“Recent advances toward preclinical and clinical translation of photoacoustic tomography: a review,”
J. Biomed. Opt., 22
(4), 041006 https://doi.org/10.1117/1.JBO.22.4.041006 JBOPFO 1083-3668
(2017).
Google Scholar
A. G. Bell,
“On the production and reproduction of sound by light,”
Am. J. Sci., s3-20
(118), 305
–324 https://doi.org/10.2475/ajs.s3-20.118.305 AJSCAP 0002-9599
(1880).
Google Scholar
J. J. M. Riksen, A.V. Nikolaev and G. Van Soest,
“Photoacoustic imaging on its way toward clinical utility: a tutorial review focusing on practical application in medicine,”
J. Biomed. Opt., 28
(12), 121205 https://doi.org/10.1117/1.JBO.28.12.121205 JBOPFO 1083-3668
(2023).
Google Scholar
I. Steinberg et al.,
“Photoacoustic clinical imaging,”
Photoacoustics, 14 77
–98 https://doi.org/10.1016/j.pacs.2019.05.001
(2019).
Google Scholar
M. Nagli et al.,
“Silicon photonic acoustic detector (SPADE) using a silicon nitride microring resonator,”
Photoacoustics, 32 100527 https://doi.org/10.1016/j.pacs.2023.100527
(2023).
Google Scholar
T. Zhao et al.,
“Minimally invasive photoacoustic imaging: current status and future perspectives,”
Photoacoustics, 16 100146 https://doi.org/10.1016/j.pacs.2019.100146
(2019).
Google Scholar
S. L. Jacques,
“Optical properties of biological tissues: a review,”
Phys. Med. Biol., 58
(11), R37
–R61 https://doi.org/10.1088/0031-9155/58/11/R37 PHMBA7 0031-9155
(2013).
Google Scholar
V. Ntziachristos and D. Razansky,
“Molecular imaging by means of multispectral optoacoustic tomography (MSOT),”
Chem. Rev., 110
(5), 2783
–2794 https://doi.org/10.1021/cr9002566 CHREAY 0009-2665
(2010).
Google Scholar
M. Taylor-Williams et al.,
“Noninvasive hemoglobin sensing and imaging: optical tools for disease diagnosis,”
J. Biomed. Opt., 27
(8), 080901 https://doi.org/10.1117/1.JBO.27.8.080901 JBOPFO 1083-3668
(2022).
Google Scholar
M. Li, Y. Tang and J. Yao,
“Photoacoustic tomography of blood oxygenation: a mini review,”
Photoacoustics, 10 65
–73 https://doi.org/10.1016/j.pacs.2018.05.001
(2018).
Google Scholar
B. Park et al.,
“Functional photoacoustic imaging: from nano- and micro- to macro-scale,”
Nano Converg., 10
(1), 29 https://doi.org/10.1186/s40580-023-00377-3
(2023).
Google Scholar
S. John et al.,
“Niche preclinical and clinical applications of photoacoustic imaging with endogenous contrast,”
Photoacoustics, 32 100533 https://doi.org/10.1016/j.pacs.2023.100533
(2023).
Google Scholar
L. V. Wang,
“Multiscale photoacoustic microscopy and computed tomography,”
Nat. Photonics, 3
(9), 503
–509 https://doi.org/10.1038/nphoton.2009.157 NPAHBY 1749-4885
(2009).
Google Scholar
L. G. Montilla et al.,
“Real-time photoacoustic and ultrasound imaging: a simple solution for clinical ultrasound systems with linear arrays,”
Phys. Med. Biol., 58
(1), N1
–N12 https://doi.org/10.1088/0031-9155/58/1/N1 PHMBA7 0031-9155
(2013).
Google Scholar
A. Karlas et al.,
“Optoacoustic imaging in endocrinology and metabolism,”
Nat. Rev. Endocrinol., 17
(6), 323
–335 https://doi.org/10.1038/s41574-021-00482-5
(2021).
Google Scholar
D. Jüstel et al.,
“Spotlight on nerves: portable multispectral optoacoustic imaging of peripheral nerve vascularization and morphology,”
Adv. Sci., 10
(19), e2301322 https://doi.org/10.1002/advs.202301322
(2023).
Google Scholar
X. L. Deán-Ben and D. Razansky,
“Portable spherical array probe for volumetric real-time optoacoustic imaging at centimeter-scale depths,”
Opt. Express, 21
(23), 28062
–28071 https://doi.org/10.1364/OE.21.028062 OPEXFF 1094-4087
(2013).
Google Scholar
H. Zhong et al.,
“Low-cost multi-wavelength photoacoustic imaging based on portable continuous-wave laser diode module,”
IEEE Trans. Biomed. Circuits Syst., 14
(4), 738
–745 https://doi.org/10.1109/TBCAS.2020.2995728
(2020).
Google Scholar
S. Zackrisson, S. van de Ven and S. S. Gambhir,
“Light in and sound out: emerging translational strategies for photoacoustic imaging,”
Cancer Res., 74
(4), 979
–1004 https://doi.org/10.1158/0008-5472.CAN-13-2387 CNREA8 0008-5472
(2014).
Google Scholar
F. Bray et al.,
“Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,”
CA Cancer J. Clin., 68
(6), 394
–424 https://doi.org/10.3322/caac.21492 CAMCAM 0007-9235
(2018).
Google Scholar
H. Sung et al.,
“Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,”
CA Cancer J. Clin., 71
(3), 209
–249 https://doi.org/10.3322/caac.21660 CAMCAM 0007-9235
(2021).
Google Scholar
D. Nasri et al.,
“Photoacoustic imaging for investigating tumor hypoxia: a strategic assessment,”
Theranostics, 13
(10), 3346
–3367 https://doi.org/10.7150/thno.84253
(2023).
Google Scholar
E. Brown, J. Brunker and S. E. Bohndiek,
“Photoacoustic imaging as a tool to probe the tumour microenvironment,”
Dis. Model Mech., 12
(7), dmm039636 https://doi.org/10.1242/dmm.039636
(2019).
Google Scholar
R. K. Jain,
“Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy,”
Science, 307
(5706), 58
–62 https://doi.org/10.1126/science.1104819 SCIEAS 0036-8075
(2005).
Google Scholar
X. Jing et al.,
“Role of hypoxia in cancer therapy by regulating the tumor microenvironment,”
Mol. Cancer, 18
(1), 157 https://doi.org/10.1186/s12943-019-1089-9
(2019).
Google Scholar
T. Dai et al.,
“Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence,”
Cell Rep., 41
(10), 111756 https://doi.org/10.1016/j.celrep.2022.111756
(2022).
Google Scholar
J. Huang et al.,
“An activatable near-infrared chromophore for multispectral optoacoustic imaging of tumor hypoxia and for tumor inhibition,”
Theranostics, 9
(24), 7313
–7324 https://doi.org/10.7150/thno.36755
(2019).
Google Scholar
L. Lin and L. V. Wang,
“The emerging role of photoacoustic imaging in clinical oncology,”
Nat. Rev. Clin. Oncol., 19
(6), 365
–384 https://doi.org/10.1038/s41571-022-00615-3
(2022).
Google Scholar
S. Manohar and M. Dantuma,
“Current and future trends in photoacoustic breast imaging,”
Photoacoustics, 16 100134 https://doi.org/10.1016/j.pacs.2019.04.004
(2019).
Google Scholar
T. Kitai et al.,
“Photoacoustic mammography: initial clinical results,”
Breast Cancer, 21
(2), 146
–153 https://doi.org/10.1007/s12282-012-0363-0 BCATDJ 0161-0112
(2014).
Google Scholar
G. Diot et al.,
“Multispectral optoacoustic tomography (MSOT) of human breast cancer,”
Clin. Cancer Res., 23
(22), 6912
–6922 https://doi.org/10.1158/1078-0432.CCR-16-3200
(2017).
Google Scholar
J. Kukačka et al.,
“Image processing improvements afford second-generation handheld optoacoustic imaging of breast cancer patients,”
Photoacoustics, 26 100343 https://doi.org/10.1016/j.pacs.2022.100343
(2022).
Google Scholar
A. Becker et al.,
“Multispectral optoacoustic tomography of the human breast: characterisation of healthy tissue and malignant lesions using a hybrid ultrasound-optoacoustic approach,”
Eur. Radiol., 28
(2), 602
–609 https://doi.org/10.1007/s00330-017-5002-x
(2018).
Google Scholar
E. Fakhrejahani et al.,
“Clinical report on the first prototype of a photoacoustic tomography system with dual illumination for breast cancer imaging,”
PLoS One, 10
(10), e0139113 https://doi.org/10.1371/journal.pone.0139113 POLNCL 1932-6203
(2015).
Google Scholar
M. Yang et al.,
“Quantitative analysis of breast tumours aided by three-dimensional photoacoustic/ultrasound functional imaging,”
Sci. Rep., 10
(1), 8047 https://doi.org/10.1038/s41598-020-64966-6 SRCEC3 2045-2322
(2020).
Google Scholar
R. Zhang et al.,
“Exploring the diagnostic value of photoacoustic imaging for breast cancer: the identification of regional photoacoustic signal differences of breast tumors,”
Biomed. Opt. Express, 12
(3), 1407
–1421 https://doi.org/10.1364/BOE.417056 BOEICL 2156-7085
(2021).
Google Scholar
M. Wang et al.,
“Functional photoacoustic/ultrasound imaging for the assessment of breast intraductal lesions: preliminary clinical findings,”
Biomed. Opt. Express, 12
(3), 1236
–1246 https://doi.org/10.1364/BOE.411215 BOEICL 2156-7085
(2021).
Google Scholar
S. Nandy et al.,
“Evaluation of ovarian cancer: initial application of coregistered photoacoustic tomography and US,”
Radiology, 289
(3), 740
–747 https://doi.org/10.1148/radiol.2018180666 RADLAX 0033-8419
(2018).
Google Scholar
W. Roll et al.,
“Multispectral optoacoustic tomography of benign and malignant thyroid disorders: a pilot study,”
J. Nucl. Med., 60
(10), 1461
–1466 https://doi.org/10.2967/jnumed.118.222174 JNMEAQ 0161-5505
(2019).
Google Scholar
A. B. E. Attia et al.,
“Noninvasive real-time characterization of non-melanoma skin cancers with handheld optoacoustic probes,”
Photoacoustics, 7 20
–26 https://doi.org/10.1016/j.pacs.2017.05.003
(2017).
Google Scholar
B. E. Dogan et al.,
“Optoacoustic imaging and gray-scale us features of breast cancers: correlation with molecular subtypes,”
Radiology, 292
(3), 564
–572 https://doi.org/10.1148/radiol.2019182071 RADLAX 0033-8419
(2019).
Google Scholar
J. Li et al.,
“Molecular breast cancer subtype identification using photoacoustic spectral analysis and machine learning at the biomacromolecular level,”
Photoacoustics, 30 100483 https://doi.org/10.1016/j.pacs.2023.100483
(2023).
Google Scholar
E. I. Neuschler et al.,
“A pivotal study of optoacoustic imaging to diagnose benign and malignant breast masses: a new evaluation tool for radiologists,”
Radiology, 287
(2), 398
–412 https://doi.org/10.1148/radiol.2017172228 RADLAX 0033-8419
(2018).
Google Scholar
G. L. G. Menezes et al.,
“Downgrading of breast masses suspicious for cancer by using optoacoustic breast imaging,”
Radiology, 288
(2), 355
–365 https://doi.org/10.1148/radiol.2018170500 RADLAX 0033-8419
(2018).
Google Scholar
R. L. Coleman et al.,
“Latest research and treatment of advanced-stage epithelial ovarian cancer,”
Nat. Rev. Clin. Oncol., 10
(4), 211
–224 https://doi.org/10.1038/nrclinonc.2013.5
(2013).
Google Scholar
S. Lheureux et al.,
“Epithelial ovarian cancer,”
Lancet, 393
(10177), 1240
–1253 https://doi.org/10.1016/S0140-6736(18)32552-2 LANCAO 0140-6736
(2019).
Google Scholar
E. Amidi et al.,
“Classification of human ovarian cancer using functional, spectral, and imaging features obtained from in vivo photoacoustic imaging,”
Biomed. Opt. Express, 10
(5), 2303
–2317 https://doi.org/10.1364/BOE.10.002303 BOEICL 2156-7085
(2019).
Google Scholar
E. Amidi et al.,
“Role of blood oxygenation saturation in ovarian cancer diagnosis using multi-spectral photoacoustic tomography,”
J. Biophotonics, 14
(4), e202000368 https://doi.org/10.1002/jbio.202000368
(2021).
Google Scholar
Y. Zou et al.,
“Ultrasound-enhanced Unet model for quantitative photoacoustic tomography of ovarian lesions,”
Photoacoustics, 28 100420 https://doi.org/10.1016/j.pacs.2022.100420
(2022).
Google Scholar
S. B. Fisher and N. D. Perrier,
“The incidental thyroid nodule,”
CA Cancer J. Clin., 68
(2), 97
–105 https://doi.org/10.3322/caac.21447 CAMCAM 0007-9235
(2018).
Google Scholar
M. E. Noltes et al.,
“Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography,”
Eur. J. Nucl. Med. Mol. Imaging, 50
(9), 2736
–2750 https://doi.org/10.1007/s00259-023-06189-1
(2023).
Google Scholar
J. Kim et al.,
“Multiparametric photoacoustic analysis of human thyroid cancers in vivo,”
Cancer Res., 81
(18), 4849
–4860 https://doi.org/10.1158/0008-5472.CAN-20-3334 CNREA8 0008-5472
(2021).
Google Scholar
M. T. Stridh et al.,
“Photoacoustic imaging of periorbital skin cancer ex vivo: unique spectral signatures of malignant melanoma, basal, and squamous cell carcinoma,”
Biomed. Opt. Express, 13
(1), 410
–425 https://doi.org/10.1364/BOE.443699 BOEICL 2156-7085
(2022).
Google Scholar
T. von Knorring and M. Mogensen,
“Photoacoustic tomography for assessment and quantification of cutaneous and metastatic malignant melanoma—a systematic review,”
Photodiagn. Photodyn. Ther., 33 102095 https://doi.org/10.1016/j.pdpdt.2020.102095
(2021).
Google Scholar
S. Y. Chuah et al.,
“Structural and functional 3D mapping of skin tumours with non-invasive multispectral optoacoustic tomography,”
Skin Res. Technol., 23
(2), 221
–226 https://doi.org/10.1111/srt.12326
(2017).
Google Scholar
M. S. Karthikesh and X. Yang,
“Photoacoustic image-guided interventions,”
Exp. Biol. Med., 245
(4), 330
–341 https://doi.org/10.1177/1535370219889323 EXBMAA 0071-3384
(2020).
Google Scholar
W. S. Tummers et al.,
“Intraoperative pancreatic cancer detection using tumor-specific multimodality molecular imaging,”
Ann. Surg. Oncol., 25
(7), 1880
–1888 https://doi.org/10.1245/s10434-018-6453-2
(2018).
Google Scholar
M. A. Lediju Bell et al.,
“Localization of transcranial targets for photoacoustic-guided endonasal surgeries,”
Photoacoustics, 3
(2), 78
–87 https://doi.org/10.1016/j.pacs.2015.05.002
(2015).
Google Scholar
P. Keša et al.,
“Quantitative in vivo monitoring of hypoxia and vascularization of patient-derived murine xenografts of mantle cell lymphoma using photoacoustic and ultrasound imaging,”
Ultrasound Med. Biol., 47
(4), 1099
–1107 https://doi.org/10.1016/j.ultrasmedbio.2020.12.010 USMBA3 0301-5629
(2021).
Google Scholar
L. J. Rich and M. Seshadri,
“Photoacoustic monitoring of tumor and normal tissue response to radiation,”
Sci. Rep., 6 21237 https://doi.org/10.1038/srep21237 SRCEC3 2045-2322
(2016).
Google Scholar
L. J. Rich et al.,
“Photoacoustic imaging as an early biomarker of radio therapeutic efficacy in head and neck cancer,”
Theranostics, 8
(8), 2064
–2078 https://doi.org/10.7150/thno.21708
(2018).
Google Scholar
J. Jo et al.,
“Personalized oncology by in vivo chemical imaging: photoacoustic mapping of tumor oxygen predicts radiotherapy efficacy,”
ACS Nano, 17
(5), 4396
–4403 https://doi.org/10.1021/acsnano.2c09502 ANCAC3 1936-0851
(2023).
Google Scholar
I. Quiros-Gonzalez et al.,
“Photoacoustic tomography detects response and resistance to Bevacizumab in breast cancer mouse models,”
Cancer Res., 82
(8), 1658
–1668 https://doi.org/10.1158/0008-5472.CAN-21-0626 CNREA8 0008-5472
(2022).
Google Scholar
A. Claus et al.,
“3D ultrasound-guided photoacoustic imaging to monitor the effects of suboptimal tyrosine kinase inhibitor therapy in pancreatic tumors,”
Front. Oncol., 12 915319 https://doi.org/10.3389/fonc.2022.915319 FRTOA7 0071-9676
(2022).
Google Scholar
J. S. Smolen et al.,
“Rheumatoid arthritis,”
Nat. Rev. Dis. Primers, 4 18001 https://doi.org/10.1038/nrdp.2018.1
(2018).
Google Scholar
Q. Guo et al.,
“Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies,”
Bone Res., 6 15 https://doi.org/10.1038/s41413-018-0016-9
(2018).
Google Scholar
M. A. D’Agostino et al.,
“Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-part 1: definition and development of a standardised, consensus-based scoring system,”
RMD Open, 3
(1), e000428 https://doi.org/10.1136/rmdopen-2016-000428
(2017).
Google Scholar
R. Caporali and J. S. Smolen,
“Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management,”
Ann. Rheum. Dis., 77
(1), 18
–20 https://doi.org/10.1136/annrheumdis-2017-211458 ARDIAO 0003-4967
(2018).
Google Scholar
H. Nguyen et al.,
“Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis,”
Rheumatology, 53
(11), 2110
–2118 https://doi.org/10.1093/rheumatology/keu217 RHEUBD 0080-2727
(2014).
Google Scholar
J. Jo et al.,
“A functional study of human inflammatory arthritis using photoacoustic imaging,”
Sci. Rep., 7
(1), 15026 https://doi.org/10.1038/s41598-017-15147-5 SRCEC3 2045-2322
(2017).
Google Scholar
P. J. van den Berg et al.,
“Feasibility of photoacoustic/ultrasound imaging of synovitis in finger joints using a point-of-care system,”
Photoacoustics, 8 8
–14 https://doi.org/10.1016/j.pacs.2017.08.002
(2017).
Google Scholar
C. Zhao et al.,
“Multimodal photoacoustic/ultrasonic imaging system: a promising imaging method for the evaluation of disease activity in rheumatoid arthritis,”
Eur. Radiol., 31
(5), 3542
–3552 https://doi.org/10.1007/s00330-020-07353-z
(2021).
Google Scholar
M. Yang et al.,
“Synovial oxygenation at photoacoustic imaging to assess rheumatoid arthritis disease activity,”
Radiology, 306
(1), 220
–228 https://doi.org/10.1148/radiol.212257 RADLAX 0033-8419
(2023).
Google Scholar
Y. Liu et al.,
“Imaging molecular signatures for clinical detection of scleroderma in the hand by multispectral photoacoustic elastic tomography,”
J. Biophotonics, 11
(6), e201700267 https://doi.org/10.1002/jbio.201700267
(2018).
Google Scholar
D. J. Veale and U. Fearon,
“The pathogenesis of psoriatic arthritis,”
Lancet, 391
(10136), 2273
–2284 https://doi.org/10.1016/S0140-6736(18)30830-4 LANCAO 0140-6736
(2018).
Google Scholar
O. FitzGerald et al.,
“Psoriatic arthritis,”
Nat. Rev. Dis. Primers, 7
(1), 59 https://doi.org/10.1038/s41572-021-00293-y
(2021).
Google Scholar
S. Hallasch et al.,
“Multispectral optoacoustic tomography might be a helpful tool for noninvasive early diagnosis of psoriatic arthritis,”
Photoacoustics, 21 100225 https://doi.org/10.1016/j.pacs.2020.100225
(2021).
Google Scholar
S. Glyn-Jones et al.,
“Osteoarthritis,”
Lancet, 386
(9991), 376
–387 https://doi.org/10.1016/S0140-6736(14)60802-3 LANCAO 0140-6736
(2015).
Google Scholar
J. Martel-Pelletier et al.,
“Osteoarthritis,”
Nat. Rev. Dis. Primers, 2 16072 https://doi.org/10.1038/nrdp.2016.72
(2016).
Google Scholar
J. Xiao and J. He,
“Multispectral quantitative photoacoustic imaging of osteoarthritis in finger joints,”
Appl. Opt., 49
(30), 5721
–5727 https://doi.org/10.1364/AO.49.005721 APOPAI 0003-6935
(2010).
Google Scholar
C. P. Denton and D. Khanna,
“Systemic sclerosis,”
Lancet, 390
(10103), 1685
–1699 https://doi.org/10.1016/S0140-6736(17)30933-9 LANCAO 0140-6736
(2017).
Google Scholar
E. R. Volkmann, K. Andréasson and V. Smith,
“Systemic sclerosis,”
Lancet, 401
(10373), 304
–318 https://doi.org/10.1016/S0140-6736(22)01692-0 LANCAO 0140-6736
(2023).
Google Scholar
F. M. Wigley and N. A. Flavahan,
“Raynaud’s phenomenon,”
N. Engl. J. Med., 375
(6), 556
–565 https://doi.org/10.1056/NEJMra1507638 NEJMAG 0028-4793
(2016).
Google Scholar
K. Daoudi et al.,
“Photoacoustic and high-frequency ultrasound imaging of systemic sclerosis patients,”
Arthritis Res. Ther., 23
(1), 22 https://doi.org/10.1186/s13075-020-02400-y
(2021).
Google Scholar
S. Wilkinson et al.,
“Photoacoustic imaging is a novel tool to measure finger artery structure and oxygenation in patients with SSc,”
Sci. Rep., 12
(1), 20446 https://doi.org/10.1038/s41598-022-23826-1 SRCEC3 2045-2322
(2022).
Google Scholar
M. Masthoff et al.,
“Multispectral optoacoustic tomography of systemic sclerosis,”
J. Biophotonics, 11
(11), e201800155 https://doi.org/10.1002/jbio.201800155
(2018).
Google Scholar
J. R. Eisenbrey et al.,
“Photoacoustic oxygenation quantification in patients with Raynaud’s: first-in-human results,”
Ultrasound Med. Biol., 44
(10), 2081
–2088 https://doi.org/10.1016/j.ultrasmedbio.2018.04.017 USMBA3 0301-5629
(2018).
Google Scholar
D. Pugh et al.,
“Large-vessel vasculitis,”
Nat. Rev. Dis. Primers, 7
(1), 93 https://doi.org/10.1038/s41572-021-00327-5
(2022).
Google Scholar
F. Buttgereit, E. L. Matteson and C. Dejaco,
“Polymyalgia rheumatica and giant cell arteritis,”
JAMA, 324
(10), 993
–994 https://doi.org/10.1001/jama.2020.10155 JAMAAP 0098-7484
(2020).
Google Scholar
M. Naumovska et al.,
“Mapping the architecture of the temporal artery with photoacoustic imaging for diagnosing giant cell arteritis,”
Photoacoustics, 27 100384 https://doi.org/10.1016/j.pacs.2022.100384
(2022).
Google Scholar
C. Abraham and J. H. Cho,
“Inflammatory bowel disease,”
N. Engl. J. Med., 361
(21), 2066
–2078 https://doi.org/10.1056/NEJMra0804647 NEJMAG 0028-4793
(2009).
Google Scholar
G. G. Kaplan and J. W. Windsor,
“The four epidemiological stages in the global evolution of inflammatory bowel disease,”
Nat. Rev. Gastroenterol. Hepatol., 18
(1), 56
–66 https://doi.org/10.1038/s41575-020-00360-x
(2021).
Google Scholar
M. J. Waldner et al.,
“Multispectral optoacoustic tomography in Crohn’s disease: noninvasive imaging of disease activity,”
Gastroenterology, 151
(2), 238
–240 https://doi.org/10.1053/j.gastro.2016.05.047 GASTAB 0016-5085
(2016).
Google Scholar
F. Knieling et al.,
“Multispectral optoacoustic tomography for assessment of Crohn’s disease activity,”
N. Engl. J. Med., 376
(13), 1292
–1294 https://doi.org/10.1056/NEJMc1612455 NEJMAG 0028-4793
(2017).
Google Scholar
A. P. Regensburger et al.,
“Multispectral optoacoustic tomography enables assessment of disease activity in paediatric inflammatory bowel disease,”
Photoacoustics, 35 100578 https://doi.org/10.1016/j.pacs.2023.100578
(2024).
Google Scholar
D. Tomic, J. E. Shaw and D. J. Magliano,
“The burden and risks of emerging complications of diabetes mellitus,”
Nat. Rev. Endocrinol., 18
(9), 525
–539 https://doi.org/10.1038/s41574-022-00690-7
(2022).
Google Scholar
J. M. Forbes and M. E. Cooper,
“Mechanisms of diabetic complications,”
Physiol. Rev., 93
(1), 137
–188 https://doi.org/10.1152/physrev.00045.2011 PHREA7 0031-9333
(2013).
Google Scholar
Y. Mantri et al.,
“Monitoring peripheral hemodynamic response to changes in blood pressure via photoacoustic imaging,”
Photoacoustics, 26 100345 https://doi.org/10.1016/j.pacs.2022.100345
(2022).
Google Scholar
C. P. Favazza, L. A. Cornelius and L. V. Wang,
“In vivo functional photoacoustic microscopy of cutaneous microvasculature in human skin,”
J. Biomed. Opt., 16
(2), 026004 https://doi.org/10.1117/1.3536522 JBOPFO 1083-3668
(2011).
Google Scholar
J. Bunke et al.,
“Photoacoustic imaging for the monitoring of local changes in oxygen saturation following an adrenaline injection in human forearm skin,”
Biomed. Opt. Express, 12
(7), 4084
–4096 https://doi.org/10.1364/BOE.423876 BOEICL 2156-7085
(2021).
Google Scholar
C. Lee et al.,
“Panoramic volumetric clinical handheld photoacoustic and ultrasound imaging,”
Photoacoustics, 31 100512 https://doi.org/10.1016/j.pacs.2023.100512
(2023).
Google Scholar
J. Yang et al.,
“Detecting hemodynamic changes in the foot vessels of diabetic patients by photoacoustic tomography,”
J. Biophotonics, 13
(8), e202000011 https://doi.org/10.1002/jbio.202000011
(2020).
Google Scholar
A. Karlas et al.,
“Flow-mediated dilatation test using optoacoustic imaging: a proof-of-concept,”
Biomed. Opt. Express, 8
(7), 3395
–3403 https://doi.org/10.1364/BOE.8.003395 BOEICL 2156-7085
(2017).
Google Scholar
A. Karlas et al.,
“Multispectral optoacoustic tomography of peripheral arterial disease based on muscle hemoglobin gradients—a pilot clinical study,”
Ann. Transl. Med., 9
(1), 36 https://doi.org/10.21037/atm-20-3321
(2021).
Google Scholar
J. Reber et al.,
“Non-invasive measurement of brown fat metabolism based on optoacoustic imaging of hemoglobin gradients,”
Cell Metab., 27
(3), 689
–701.e4 https://doi.org/10.1016/j.cmet.2018.02.002 1550-4131
(2018).
Google Scholar
U. A. Okonkwo and L. A. DiPietro,
“Diabetes and wound angiogenesis,”
Int. J. Mol. Sci., 18
(7), 1419 https://doi.org/10.3390/ijms18071419 1422-0067
(2017).
Google Scholar
Y. Mantri et al.,
“Photoacoustic imaging to monitor outcomes during hyperbaric oxygen therapy: validation in a small cohort and case study in a bilateral chronic ischemic wound,”
Biomed. Opt. Express, 13
(11), 5683
–5694 https://doi.org/10.1364/BOE.472568 BOEICL 2156-7085
(2022).
Google Scholar
M. Petri et al.,
“Oxygenation status in chronic leg ulcer after topical hemoglobin application may act as a surrogate marker to find the best treatment strategy and to avoid ineffective conservative long-term therapy,”
Mol. Imaging Biol., 20
(1), 124
–130 https://doi.org/10.1007/s11307-017-1103-9
(2018).
Google Scholar
Y. Mantri et al.,
“Photoacoustic monitoring of angiogenesis predicts response to therapy in healing wounds,”
Wound Repair Regen., 30
(2), 258
–267 https://doi.org/10.1111/wrr.12992
(2022).
Google Scholar
J. P. Walsh,
“Managing thyroid disease in general practice,”
Med. J. Aust., 205
(4), 179
–184 https://doi.org/10.5694/mja16.00545 MJAUAJ 0025-729X
(2016).
Google Scholar
M. Yang et al.,
“Photoacoustic/ultrasound dual imaging of human thyroid cancers: an initial clinical study,”
Biomed. Opt. Express, 8
(7), 3449
–3457 https://doi.org/10.1364/BOE.8.003449 BOEICL 2156-7085
(2017).
Google Scholar
L. V. Wang and S. Hu,
“Photoacoustic tomography: in vivo imaging from organelles to organs,”
Science, 335
(6075), 1458
–1462 https://doi.org/10.1126/science.1216210 SCIEAS 0036-8075
(2012).
Google Scholar
K. S. Valluru and J. K. Willmann,
“Clinical photoacoustic imaging of cancer,”
Ultrasonography, 35
(4), 267
–280 https://doi.org/10.14366/usg.16035
(2016).
Google Scholar
B. Cox et al.,
“Quantitative spectroscopic photoacoustic imaging: a review,”
J. Biomed. Opt., 17
(6), 061202 https://doi.org/10.1117/1.JBO.17.6.061202 JBOPFO 1083-3668
(2012).
Google Scholar
J. Yao and L. V. Wang,
“Photoacoustic microscopy,”
Laser Photonics Rev., 7
(5), 758
–778 https://doi.org/10.1002/lpor.201200060
(2013).
Google Scholar
M. Sivaramakrishnan et al.,
“Limitations of quantitative photoacoustic measurements of blood oxygenation in small vessels,”
Phys. Med. Biol., 52
(5), 1349
–1361 https://doi.org/10.1088/0031-9155/52/5/010 PHMBA7 0031-9155
(2007).
Google Scholar
J. Joseph et al.,
“Evaluation of precision in optoacoustic tomography for preclinical imaging in living subjects,”
J. Nucl. Med., 58
(5), 807
–814 https://doi.org/10.2967/jnumed.116.182311 JNMEAQ 0161-5505
(2017).
Google Scholar
H. Deng et al.,
“Deep learning in photoacoustic imaging: a review,”
J. Biomed. Opt., 26
(4), 040901 https://doi.org/10.1117/1.JBO.26.4.040901 JBOPFO 1083-3668
(2021).
Google Scholar
C. Yang et al.,
“Review of deep learning for photoacoustic imaging,”
Photoacoustics, 21 100215 https://doi.org/10.1016/j.pacs.2020.100215
(2021).
Google Scholar
H. Assi et al.,
“A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: from current barriers to future adoption,”
Photoacoustics, 32 100539 https://doi.org/10.1016/j.pacs.2023.100539
(2023).
Google Scholar
BiographyHuazhen Liu received her MD from Peking Union Medical College (PUMC). She is a postdoctoral researcher in the Department of Ultrasound, PUMC Hospital. Her research interests focus on the clinical applications of photoacoustic imaging, with a particular emphasis on rheumatoid arthritis and oncology. Ming Wang received her MD from PUMC Hospital in 2014. She was an attending physician in the Department of Ultrasound, PUMC Hospital, where she participated in research on breast imaging and musculoskeletal imaging. Since 2017, she has been involved in clinical studies on photoacoustic/ultrasound functional imaging, with a specific focus on its clinical application for breast cancer. Fei Ji is a resident in ultrasonography at PUMC Hospital, China. Her research interests pertain to gynecological disease, musculoskeletal disease, and multimodal photoacoustic/ultrasonic imaging system. Yuxin Jiang is a professor in the Department of Ultrasound Medicine, PUMC Hospital. He holds the China branch chairman position at the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) and serves as the vice chairman of the Asian Federation for Societies of Ultrasound in Medicine and Biology (AFSUMB). His professional interests include breast cancer, thyroid and parathyroid diseases, kidney disorders, and the application of contrast-enhanced ultrasonography in liver and thyroid diseases. Meng Yang received her MD from PUMC, Beijing, China and pursued postdoctoral research at the Molecular Imaging Program at Stanford University (MIPS). Currently, she serves as a chief physician at PUMC Hospital. Her interests span the development of photoacoustic/ultrasound (PA/US) imaging systems and the clinical translation of PA/US imaging in thyroid, breast, dermatologic, musculoskeletal, and obstetrics and gynecology diseases. |
Tumors
Imaging systems
Diseases and disorders
Biological imaging
Vascular diseases
Thyroid
Photoacoustic imaging